Back to Search
STANLEY BALCERZAK, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1972935716Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
35. 030009(OH)
Research & Publications (20)
A phase I and pharmacokinetic study of weekly oxaliplatin followed by paclitaxel in patients with solid tumors.
PMID 18519774·Clin Cancer Res·2008
3-trial
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500).
PMID 17696203·Am J Hematol·2007
3-trial
A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group study.
PMID 15292717·Invest New Drugs·2004
3-trial
Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas.
PMID 18521404·Sarcoma·2004
8-other
A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study.
PMID 15122082·Invest New Drugs·2004
3-trial
A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.
PMID 15111772·Breast Cancer Res Treat·2004
3-trial
Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia.
PMID 12393493·Blood·2003
3-trial
Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.
PMID 12972528·J Clin Oncol·2003
3-trial
High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.
PMID 12872353·Cancer·2003
3-trial
Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501.
PMID 12743154·J Clin Oncol·2003
3-trial
Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study.
PMID 12393614·Blood·2002
3-trial
Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
PMID 12451470·Cancer Chemother Pharmacol·2002
4-observational
Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients.
PMID 11976830·Cancer Chemother Pharmacol·2002
3-trial
A phase II study of CI-980 in previously untreated extensive small cell lung cancer: an Ohio State University phase II research consortium study.
PMID 11901539·Cancer Invest·2002
3-trial
A phase II study of topotecan in non-Hodgkin's lymphoma: an Ohio State University phase II research consortium study.
PMID 11901536·Cancer Invest·2002
3-trial
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.
PMID 11895901·Clin Cancer Res·2002
3-trial
Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study.
PMID 11236936·Leukemia·2001
3-trial
Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: a Southwest Oncology Group Study.
PMID 11157027·J Clin Oncol·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3113 N 3 BS AND K RD
SUNBURY, OH 43074 - Phone
- (740) 524-7191
Quick Facts
- NPI
- 1972935716
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile